Sanofi Pasteur
- Address
- 14 Espace Henry Vallee
Sponsor Overview
Specializations
Influenza Prevention in Older Adults
Clinical research in influenza vaccination focuses on older adults, with interest in quadrivalent influenza vaccines and protection against influenza-related hospitalisation and pneumonia. The work reflects a clear emphasis on age-related respiratory infection prevention.
- Older adult immunisation
- Quadrivalent influenza vaccine
- Influenza-related hospitalisation
- Pneumonia prevention
These studies are centred on improving protection against seasonal respiratory disease in ageing populations.
Meningococcal Disease and Conjugate Vaccines
Research activity includes meningococcal infection and meningococcal ACYW conjugate vaccines, with attention to immune responses against serogroups A, C, W, and Y. The sponsor’s portfolio covers both primary immunisation and booster vaccination across childhood and adolescence.
- MenACYW conjugate vaccine
- Meningococcal serogroups A, C, W, and Y
- Booster immunisation
- Paediatric and adolescent vaccination
Interest extends to durable immune protection after earlier childhood vaccination and later revaccination.
Yellow Fever Vaccination
Clinical studies also address yellow fever prevention through investigation of an investigational yellow fever vaccine in adults. The research is directed toward maintaining vaccine-induced protection against this mosquito-borne viral infection.
- Yellow fever immunisation
- Investigational vaccine
- Adult vaccination
- Viral infection prevention
This area reflects ongoing interest in travel and endemic-disease vaccination.
Healthy Volunteers in Vaccine Immunogenicity Research
Some studies involve healthy volunteers to assess antibody response, seroconversion, and immune persistence after vaccination. This supports evaluation of how well vaccines stimulate and maintain protective immunity in populations without active disease.
- Healthy volunteer studies
- Antibody response
- Seroconversion
- Immune persistence
The research spans multiple age groups, including infants, toddlers, children, adolescents, adults, and older adults.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults |  Denmark | Not Recruiting |
| Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril® in Adults |  Finland France Germany Spain | Not Recruiting |
| Evaluation of Immunogenicity and Safety of MenACYW Conjugate Vaccine Booster in Pediatric and Adolescent Populations with Prior Vaccination | Finland Germany Hungary Spain | Not Recruiting |
| Phase III Study on Immunogenicity and Safety of MenACYW Conjugate Vaccine Versus Nimenrix in Healthy Infants and Toddlers |  Czechia Denmark Finland Germany Poland Romania | Not Recruiting |
Data & Insights
This sponsor works with 15 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 79 sites across their trial portfolio.
Therapeutic Focus
- 1.Bacterial Infections and Mycoses2 trials180 other sponsors
- 2.Virus Diseases2 trials182 other sponsors
Partnered Research Centres
79 centres- Address
- Éder György utca 4, 3527 Miskolc
- Address
- Moelleparkvej 4, 9000 Aalborg
- Address
- Palle Juul-Jensens Boulevard 99, 8200 Aarhus
- Address
- 27 Rue du Faubourg Saint-Jacques, 75014 Paris
- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
- Address
- Friedrichstrasse 134, Mitte, 10117 Berlin
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Sanofi Pasteur.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.